Staidson Beijing Biopharma Cash Flow Conversion Efficiency

Latest as of September 2025: -0.046x

Staidson Beijing Biopharma cash flow conversion efficiency. Based on the latest financial reports, Staidson Beijing Biopharma (300204) has a cash flow conversion efficiency ratio of -0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-39.18 Million ≈ $-5.73 Million USD) by net assets (CN¥859.70 Million ≈ $125.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Staidson Beijing Biopharma (2007–2025)

Cash flow conversion efficiency of Staidson Beijing Biopharma from 2007 to 2025. This chart illustrates how Staidson Beijing Biopharma's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Staidson Beijing Biopharma (300204) share price today for real-time trading data and today's change.

Staidson Beijing Biopharma Cash Flow Conversion Ratio Explained

Staidson Beijing Biopharma cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Staidson Beijing Biopharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Staidson Beijing Biopharma ranked by their cash flow conversion efficiency. Also see 300204 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Anhui Guangxin Agrochemical Co Ltd SHG:603599	0.011x
Opera Ltd NASDAQ:OPRA	0.022x
Shenzhen Qingyi Photomask Ltd SHG:688138	0.031x
MeHow Innovative Ltd. A SHE:301363	N/A
Beijing Bei Mo Gao Ke Friction Mate SHE:002985	0.056x
Banvida SN:BANVIDA	0.010x
One Software Technologies Ltd TA:ONE	0.082x
Sobha Limited NSE:SOBHA	0.062x

Annual Cash Flow Conversion Efficiency for Staidson Beijing Biopharma (2007–2025)

The table below shows the annual cash flow conversion efficiency of Staidson Beijing Biopharma from 2007 to 2025. Review Staidson Beijing Biopharma free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥806.72 Million ≈ $118.05 Million	CN¥-125.68 Million ≈ $-18.39 Million	-0.156x	-124.28%
2024-12-31	CN¥916.76 Million ≈ $134.15 Million	CN¥-63.68 Million ≈ $-9.32 Million	-0.069x	+68.83%
2023-12-31	CN¥1.02 Billion ≈ $149.36 Million	CN¥-227.47 Million ≈ $-33.29 Million	-0.223x	-71.83%
2022-12-31	CN¥1.35 Billion ≈ $198.11 Million	CN¥-175.60 Million ≈ $-25.70 Million	-0.130x	-24.10%
2021-12-31	CN¥1.55 Billion ≈ $226.92 Million	CN¥-162.07 Million ≈ $-23.72 Million	-0.105x	-44.78%
2020-12-31	CN¥1.59 Billion ≈ $232.30 Million	CN¥-114.60 Million ≈ $-16.77 Million	-0.072x	-366.21%
2019-12-31	CN¥1.64 Billion ≈ $239.29 Million	CN¥44.34 Million ≈ $6.49 Million	0.027x	-59.63%
2018-12-31	CN¥2.46 Billion ≈ $359.66 Million	CN¥165.08 Million ≈ $24.16 Million	0.067x	-45.77%
2017-12-31	CN¥2.21 Billion ≈ $323.30 Million	CN¥273.64 Million ≈ $40.04 Million	0.124x	+11.78%
2016-12-31	CN¥1.92 Billion ≈ $280.70 Million	CN¥212.55 Million ≈ $31.10 Million	0.111x	-19.24%
2015-12-31	CN¥1.68 Billion ≈ $246.39 Million	CN¥231.01 Million ≈ $33.80 Million	0.137x	+0.44%
2014-12-31	CN¥1.51 Billion ≈ $221.60 Million	CN¥206.85 Million ≈ $30.27 Million	0.137x	+61.17%
2013-12-31	CN¥1.31 Billion ≈ $192.28 Million	CN¥111.36 Million ≈ $16.30 Million	0.085x	+16.61%
2012-12-31	CN¥1.24 Billion ≈ $181.57 Million	CN¥90.19 Million ≈ $13.20 Million	0.073x	-7.94%
2011-12-31	CN¥1.10 Billion ≈ $161.27 Million	CN¥87.01 Million ≈ $12.73 Million	0.079x	-79.46%
2010-12-31	CN¥166.23 Million ≈ $24.32 Million	CN¥63.91 Million ≈ $9.35 Million	0.384x	+8.64%
2009-12-31	CN¥119.72 Million ≈ $17.52 Million	CN¥42.37 Million ≈ $6.20 Million	0.354x	+36.99%
2008-12-31	CN¥62.82 Million ≈ $9.19 Million	CN¥16.23 Million ≈ $2.37 Million	0.258x	+61.81%
2007-12-31	CN¥33.87 Million ≈ $4.96 Million	CN¥5.41 Million ≈ $791.30K	0.160x	--

About Staidson Beijing Biopharma

SHE:300204 China Biotechnology

Market Cap

$1.37 Billion

CN¥9.39 Billion CNY

Market Cap Rank

#7349 Global

#1546 in China

Share Price

CN¥17.35

Change (1 day)

+3.64%

52-Week Range

CN¥16.73 - CN¥39.30

All Time High

CN¥61.00